Umbilical cord mesenchymal stromal cells attenuate experimental lupus and modulate CD3ζ expression in CD4⁺ T cells
Year: 2026
Type: article
Abstract: CD3ζ, encoded by SLE susceptibility gene CD247, is essential for TCR signaling and T cell responses. While genetically linked to systemic lupus erythematosus (SLE), its role in SLE progression remains unclear. Flow cytometry quantified CD4⁺CD3ζ dim T-cell frequencies and IFN-γ production in patients with SLE and lupus mouse models. A genetic model with reduced CD3ζ expression in the CD4 lineage was evaluated in resiquimod- and pristane-induced lupus. Changes associated with mesenchymal stromal cell transplantation (MSCT) were assessed in lupus mice. Co-immunoprecipitation and protein degradation assays investigated CD3ζ regulation and the effects of MSC-derived extracellular vesicles (MSC-EVs) in vitro. CD4⁺CD3ζ dim T-cell frequencies were increased in patients with SLE and lupus mice. These cells exhibited greater IFN-γ production than CD4⁺CD3ζ bright T cells. Mice with CD4-lineage CD3ζ reduction showed more severe induced lupus manifestations, including increased B-cell and plasmablast responses and exacerbated proteinuria. MSCT-treated mice showed improved disease manifestations, accompanied by lower CD4⁺CD3ζ dim T-cell frequencies and reduced IFN-γ production. In vitro, TRIM21 associated with CD3ζ and was implicated in the negative regulation of its protein abundance. TRIM21 expression was inversely associated with CD3ζ expression in lupus and MSC-EVs increased CD3ζ protein expression and modulated TRIM21 in vitro. CD4⁺CD3ζ dim T cells are more frequent in patients with SLE and lupus mice and exhibit greater IFN-γ production than CD4⁺CD3ζ bright T cells. Mice with genetically reduced CD3ζ expression in the CD4 lineage exhibit aggravated disease manifestations following resiquimod or pristane induction. MSCT-treated mice show improved lupus manifestations and reduced TRIM21 expression. In vitro findings support the involvement of TRIM21 in regulating CD3ζ abundance and show that MSC-EVs increase CD3ζ protein expression.
Source: Stem Cell Research & Therapy
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W7235617186
